Hawthorn, a shrub, yields leaf-and-flower extracts sold as heart-tonic supplements, mostly studied in heart patients; benefit for others remains uncertain. In mild heart failure, small trials found better exercise tolerance, unconfirmed by the most careful independent trial; the largest did not reduce heart events. Pooled small trials point to a modest, inconsistent fall in raised upper blood-pressure readings. It appears well tolerated; Mexican hawthorn root products contained a poisonous plant. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood pressure | <130/80 mmHg | Expected to change |
| Resting heart rate | 60–100 beats per minute | Safety check: unexpected slowing stops use |
| Serum digoxin (digoxin users only) | 0.5–2.0 ng/mL | Safety check: unexpected change prompts review |
| NT-proBNP (heart failure only) | No established target; track change from own baseline | Safety check: a rise signals worsening heart failure |
| Ejection fraction (heart failure only) | Not specified in the ER | Baseline reference point |
| Body weight (heart failure only) | Not specified in the ER | Safety check: tracks early heart failure worsening |
Cadence: Baseline before starting; blood pressure and pulse at 2 and 4 weeks, then every 3 months; in heart failure, weight and symptoms weekly for the first 2 months and natriuretic peptide at 3 months, then every 6–12 months; digoxin users keep their scheduled levels